25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension - Is it worth the "hype"?

Erin D. Michos, Pamela L. Lutsey

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)237-239
Number of pages3
JournalAtherosclerosis
Volume245
DOIs
StatePublished - Feb 1 2016

Keywords

  • Commentary
  • Coronary heart disease
  • Hypertension
  • Risk reclassification
  • Vitamin D

Cite this